Aignostics, a spin-off of Charité – Universitätsmedizin Berlin and alumnus of the Berlin Institute of Health Digital Health Accelerator Program, has been named to Newsweek’s inaugural ranking of the “World’s Best Digital Health Companies 2024.”
On 28 February 2024, the team from Charité BIH Innovation (CBI) - the joint technology transfer of Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) - was delighted to receive a visit from Prof. Heyo. K. Kroemer, Chairman of the Executive Board of Charité, Prof. Dr Joachim Spranger, Dean of Charité, Prof. Dr Christopher…
Twice a year, the start-up competition Gründungswettbewerb – Digitale Innovationen by the Federal Ministry for Economic Affairs and Climate Protection's (BMWK) honors the best ideas of innovative start-ups that are based on digital technologies. The award supports start-ups in the early stages and emphasizes their key role as drivers of innovation…
On May 31, 2023, the sixth annual Demo Day of the BIH Digital Health Accelerator Program took place, bringing together a diverse group of innovative minds in the heart of Berlin. The event, hosted by the Berlin Institute of Health at Charité (BIH), showcased seven exceptional teams of Charité/BIH clinicians and researchers presenting their digital…
The Gütig lab uses analytical and numerical modeling techniques to identify the computational principles underlying spike based information processing and learning in central nervous systems and to understand how these principles are implemented by biological processes. Specifically, the lab focuses on the role of action potential timing in sensory…
Chronic low back pain is a significant public health problem in industrialized society. The intact spine carries the upper body and external loads, allows motion in a physiological range and protects the spinal cord. These different demands necessitate a high degree of complexity with various sources for disorders and pain. The BIH - Julius Wolff…
The Medical Omics lab aims to improve healthcare and basic research by providing artificial intelligence-driven tools for the analysis of large biomedical datasets. For comprehensive insights in disease entities, we aim to include multiple layers of data, such as single-cell RNA sequencing, methylomics data and medical imaging. In close…
Common metabolic disorders such as obesity, insulin resistance and type 2 diabetes have both environmental and genetic causes. We now know that many sections of the genome influence the risk of weight gain or adverse fat distribution, in addition to the important roles played by lack of physical activity and excessive intake of high-calorie foods.…
Defects in musculoskeletal tissues, e.g. in consequence of a trauma, do not always heal spontaneously but require surgical intervention. Biomaterials implanted into the defect region have to potential to support the healing process. We investigate the interaction between cells, their surrounding extracellular matrix and biomaterials for the…